GlassScriptPhysician profile
Suhag Patel
NPI 1891305579
$19,235.00
in general payments reported to CMS, 2019-2025
19 companies · $5,397 in 2025
The $5,397 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $574 · 2022: $1,143 · 2023: $4,239 · 2024: $7,883 · 2025: $5,397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Food and Beverage: $5,387 · Travel and Lodging: $407 · Education: $25.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,700.00 |
| Food and Beverage | $5,386.55 |
| Travel and Lodging | $406.93 |
| Education | $25.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13,016.25 | 2023-2025 | |
| Livanova USA, INC. | $1,069.34 | 2022-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Emd Serono, INC. | $792.07 | 2024-2025 | Mavenclad |
| Nevro Corp. | $720.30 | 2022-2024 | Senza, Vyrsa V1 |
| Novartis Pharmaceuticals Corporation | $676.85 | 2022-2024 | |
| Pfizer INC. | $445.41 | 2024-2025 | |
| Novo Nordisk INC | $418.23 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $310.97 | 2022 | |
| Lundbeck LLC | $281.15 | 2022-2024 | Vyepti |
| Celgene Corporation | $268.05 | 2023-2024 | Zeposia |
| Amgen INC. | $221.13 | 2021-2022 | |
| Lilly USA, LLC | $217.44 | 2021-2025 | Kisunla |
| Medtronic, INC. | $196.01 | 2023-2024 | Percept PC Brainsense |
| Ucb, INC. | $125.00 | 2025 | Rystiggo |
| Astrazeneca Pharmaceuticals LP | $124.74 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tg Therapeutics, INC. | $121.51 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $116.42 | 2023 | Zeposia |
| Biogen, INC. | $75.60 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $38.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suhag Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.